Generic Eldepril
Description: Eldepril (Selegiline) is used to treat the symptoms of Parkinson's disease. Eldepril (Selegiline) may also be used to treat other conditions as determined by your doctor. Click for more Eldepril details.
What is Generic Eldepril?
Generic Eldepril, like all generics, is the name given to the
prescription Selegiline medication manufactured by any company other than the
original inventor of Eldepril. The only true difference between brand name Eldepril
and generic Eldepril is that generic Eldepril is always less expensive.
Other common names: Carbex, Eldepryl, Jumexal, Niar, Novo-Selegiline, Plurimen, SD Deprenyl, Selegilina, Selegilinum, Selgin, Selegiline (generic name).
Generic Eldepril is at Freedom Pharmacy | *** SAVE 5% MORE WITH DISCOUNT CODE: MYN-05 *** | | Medication | Strength | Quantity | Price | Freedom Pharmacy | | Selgin - Generic Selegiline | 5 mg | 100 tablets | $87.19 | Order | | Selgin - Generic Selegiline | 5 mg | 200 tablets | $117.14 | Order | | Selgin - Generic Selegiline | 5 mg | 400 tablets | $165.59 | Order |
Generic Eldepril manufactured by Orion Corporation, Procythol Tab Btx produced by Sanofi-Aventis Aebe, and Selegilin by Stadapharm, Aliud Pharma, and Neuraxpharm are at Goldpharma | Medication | Strength | Quantity | Price | Goldpharma | | Plurimen | 5 mg | 20 tablets | $12.82 | Order | | Procythol Tab Btx | 5 mg | 50 tablets | $14.31 | Order | | Selegilin | 4.19 mg | 30 tablets | $35.27 | Order | | Selegilin | 4.19 mg | 60 tablets | $51.21 | Order | | Selegilin | 4.19 mg | 100 tablets | $72.73 | Order | | Selegilin | 8.37 mg | 30 tablets | $52.10 | Order | | Selegilin | 8.37 mg | 60 tablets | $85.39 | Order | | Selegilin | 8.37 mg | 100 tablets | $129.78 | Order |
Buy Generic Eldepril - No Prior Prescription Needed*
How To Buy Generic Eldepril Online
Buy discount generic Eldepril (Selegiline) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Eldepril - Health Bulletin
Trial Therapy Improves Melanoma SurvivalWEDNESDAY, Aug. 18 (HealthDay News) -- An experimental drug for metastatic melanoma prolonged median survival from 6.4 months to 10 months, which, although seemingly small, represents a significant extension of life for this normally intractable disease, a new study found. And a subgroup of patients given the drug, known as ipilimumab, lived as long as six years, according to research published in the Aug. 19 issue of the New England Journal of Medicine. Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|
|
